Specific mutations directly affecting GLUT1 protein expression and function are causing serious but rare disease conditions [7,8], while relatively small changes in the expression level of this protein in the key target tissues may have considerable effects in major complex metabolic diseases, including type 2 diabetes and Alzheimer’s disease [9,10]. This evidence concerns the gene SLC2A1 and early-onset autosomal dominant Alzheimer disease.